WallStSmart
STSS

Sharps Technology Inc

NASDAQ: STSS · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$1.96
-10.07% today

Updated 2026-06-03

Market cap
$79.57M
P/E ratio
P/S ratio
201.53x
EPS (TTM)
$-64.49
Dividend yield
52W range
$1 – $18
Volume
0.3M

Sharps Technology Inc (STSS) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20072019202020212022202320242025
Operating cash flow$-2.34M$-1.57M$-1.88M$-3.15M$-6.43M$-8.51M$-6.93M$-16.72M
Capital expenditures$67412.00$11176.00$312200.00$2.27M$752340.00$698277.00$138804.00$3.00
Depreciation
Stock-based comp$399.00$485198.00$1.20M$1.01M$963023.00$520830.00$107.47M
Free cash flow$-2.41M$-1.58M$-2.20M$-5.42M$-7.19M$-9.21M$-7.07M$-16.72M
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash

Frequently asked questions

What is Sharps Technology Inc's revenue?

Sharps Technology Inc's trailing twelve-month revenue is $396900.00. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is STSS?

In its most recent fiscal year, STSS ran a gross margin of -202.49%, an operating margin of -6,512.09%, and a net margin of -138,400.02%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does STSS generate?

STSS produced $-16.72M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.